Key result
In a cohort of 207 children with Kawasaki disease, 87.5% of coronary anomalies completely regressed, while absence of IVIG treatment was associated with a lower regression rate.
Why the study?
The medium to long term prognosis of children with Kawasaki disease remains unclear.
Does treatment with intravenous immunoglobulins improve the regression rate of coronary aneurysms in patients with Kawasaki disease?
Cohort (n=207)
No
Does treatment with intravenous immunoglobulins improve the regression rate of coronary aneurysms in patients with Kawasaki disease?
The medium to long-term prognosis after Kawasaki disease is excellent, with high rates of coronary aneurysm regression, though patients not treated with immunoglobulins, boys, and those outside the usual age range are at higher risk for unfavorable outcomes.
Answers are grounded in this paper and cite their sources.
May support IVIG to improve aneurysm regression in Kawasaki disease; hypothesis-generating and requires randomized confirmation.
Kawasaki disease is an acute vasculitis with a particular involvement of the coronary arteries. Coronary artery aneurysms develop in 20% of untreated children. It has been shown that early treatment with intravenous immunoglobulins and aspirin decreases this risk to 5%, but the medium to long term prognosis of children with Kawasaki disease is still unclear. To determine the outcome of the disease and risk factors for poor evolution, we reviewed retrospectively the medical records of all patients with a diagnosis of Kawasaki disease at our Institution between 1981 and 2014. Among the 207 patients included in the study, 96 patients had coronary diameter anomalies (46.4%) at diagnosis and children with atypical ages for Kawasaki disease ( 10 year of age) were more often affected with aneurysms or dilatations. 84 of them had complete regression of coronary aneurysms during the follow-up (87.5%) Absence of immunoglobulins in the acute phase was associated with less regression rate (57.1% vs 92.2%), and boys had greater z-scores at last echocardiography, statistically significant for the left anterior descending artery. We found rare complications after the acute phase documented in our patient charts (only 3.8 %). Recurrence of the disease occurred in 5 children (2.4%) and myocardial ischemia in 3 patients (1.4%), all with initial coronary aneurysm. Conclusion: medium to long term prognosis after Kawasaki disease is excellent. Boys, patients not treated with immunoglobulins or outside the usual age range are more at risk for an unfavorable outcome.
No takes yet. Share an insight, caveat, or question.
Harpe et al. (2019) conducted a cohort in Kawasaki Disease (n=207). Intravenous immunoglobulin (IVIG) vs. No IVIG was evaluated on Regression of coronary artery aneurysms or dilatations (p=0.07). In a cohort of 207 children with Kawasaki disease, 87.5% of coronary anomalies completely regressed, while absence of IVIG treatment was associated with a lower regression rate.
Synapse has enriched 10 related papers. Consider them for comparative context: